New research confirms the link between the Epstein-Barr virus and the development of multiple sclerosis, revealing mechanisms that may explain the immune system’s mistaken response. These findings open up new possibilities for innovative treatment methods for the disease.
A new study has shown that the T-cell receptor remains closed until it encounters an antigen, rather than always being open as previously believed. This discovery could help improve immunotherapy and vaccine development.
A new study has shown that urolithin A, a compound produced in the gut when consuming pomegranates and nuts, can rejuvenate the immune system and boost its effectiveness in middle-aged individuals. This substance improves the function of immune cells and may slow down age-related changes.